May Measurement Month 2021: an analysis of blood pressure screening results from Mexico
Author(s)
Alcocer, Luis
Palomo, Silvia
Rangel-Zertuche, Ricardo A
Berumen-Lechuga, María Guadalupe
Medina-Serrano, Julio M
Type
Journal Article
Abstract
May Measurement Month 2021 (MMM21) in Mexico was an opportunistic survey that aimed to improve blood pressure awareness at the individual and population levels and to analyse the impact of the COVID-19 pandemic on the prevalence, knowledge, and rates of hypertension in the country. This survey followed the methodology of MMM, previously published. The total number of participants screened was 77 547, of which 47 793 (61.6%) were female and 29 178 (37.6%) were male. The mean age (SD) was 46.2 (16.6) years. Of all 77 547 participants, 14 939 (19.3%) had hypertension, of which 48% were aware. The frequency and awareness of hypertension in this survey are similar to those reported before the pandemic (MMM19-Mexico and the 2019 National Health Survey), suggesting that the impact of the COVID-19 pandemic in these parameters of arterial hypertension was not as important as expected. These data are concordant with the official reports in Mexico that showed that the pandemic had a severe impact on cardiovascular mortality but did not modify mortality due to hypertension or stroke.
Date Issued
2024-06
Date Acceptance
2024-07-01
Citation
European Heart Journal Supplements, 2024, 26 (Supplement 3), pp.iii58-iii60
ISSN
1520-765X
Publisher
Oxford University Press
Start Page
iii58
End Page
iii60
Journal / Book Title
European Heart Journal Supplements
Volume
26
Issue
Supplement 3
Copyright Statement
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39055585
Subjects
Control
COVID-19 pandemic
Hypertension
Mexico
Screening
Treatment
Publication Status
Published
Coverage Spatial
England
Article Number
suae055
Date Publish Online
2024-07-24